Dash Bio Raises $30 Million Series A to Modernize Bioanalysis for Drug Development

Dash Bio has raised $30 million in Series A financing to expand its automation-driven bioanalysis platform, positioning the company to... Read More

The post Dash Bio Raises $30 Million Series A to Modernize Bioanalysis for Drug Development appeared first on citybiz.